Arava

Arava® (leflunomide) is a prescription drug manufactured by Aventis Pharma for the treatment of rheumatoid arthritis. Since its approval by the U.S. Food and Drug Administration ("FDA") on September 10, 1998, it is estimated that 1.5 million prescriptions for Arava® have been filled in the United States.

On March 28, 2002, the consumer advocacy group Public Citizen petitioned the FDA for the removal of Arava®. The petition to the FDA states that, "[f]rom when it was first marketed in late September 1998 through September 2001, Arava® has been associated with at least 130 severe hepatic reactions including 56 hospitalizations and 22 deaths, two of whom were patients in their twenties."

Public Citizen's analysis of available Arava® data "found not only many cases of severe drug-induced hepatotoxicity, but also large numbers of lymphomas as well as other hematologic, gastrointestinal, and skin reactions serious enough to cause hospitalizations and deaths, and a large number of cases of drug-induced hypertension."

Another danger of the drug is that it remains in body tissues for an extremely long time. Warnings already on its packaging suggest that byproducts could remain in the body for months, so that even if patients stopped taking the drug after an adverse reaction started, the damage could continue to affect patients for months.

Public Citizen compared Arava® to Methotrexate, an equally or more effective rheumatoid arthritis treatment, over a 3 year period. During that time period, there were 5.5 times more prescriptions filled for Methotrexate than Arava®. Arava® was linked to six times more reports of fatal liver toxicity and 13 times more reports of hypertension than Methotrexate. Additionally, with Arava® there were numerous cases of Stevens-Johnson syndrome, a life threatening auto-immune disease involving the skin and the mucous membranes, where with Methotrexate, there were none.

If you or a loved one is in need of legal assistance, call Robert Boyd and Associates at (601) 925-5511or Toll Free at (866) 925-HURT or submit an online questionnaire. The initial consultation is free of charge, and if we agree to handle your case, we will work on a contingency fee basis, which means we get paid for our services only if there is a monetary recovery of funds. In many cases, a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. Please call right away to ensure that you do not waive your right to possible compensation.

Robert Boyd and Associates serves the entire state of Mississippi, such as the following cities: Jackson, Clinton, Byram, Raymond, Terry, Bolton, Edwards, Brandon, Pearl, Brookhaven, Canton, Crystal Springs, Fayette, Florence, Hazlehurst, Lexington, Marion, Newton, Port Gibson, Richland, Madison, Ridgeland, McComb, Summit, Vicksburg, Wesson, Woodville, Yazoo City, Biloxi, Gulfport, Long Beach, Ocean Springs, Pascagoula, Moss Point, Pass Christian, Waveland, Clarksdale, Cleveland, Columbus, Columbia, Corinth, Greenville, Greenwood, Grenada, Hattiesburg, Magee, Tylertown, Laurel, Lucedale, Meridian, Natchez, Olive Branch, Southaven, Oxford, Philadelphia, Picayune, Starkville, Tupelo, Batesville, Aberdeen, Belzoni, Bentonia, Carthage, Kosciusko, Louisville, Cleveland, Leland, Clarksdale, Durant, Lexington, Ellisville, Florence, Flowood, Forest, Flora, Hollandale, Holly Springs, Horn Lake, Houston, Indianola, New Albany, Senatobia, Raleigh, Waynesboro, Wiggins, and Winona.

Robert Boyd and Associates is a member of NAPIL

This is an advertisement. The information supplied on this web site is general in nature and should not be relied upon to make legal decisions. This site is intended to provide you with information about our firm and practice. Use of the site, however, does not create an attorney-client relationship. Interacting with e-mail or online forums on this web site does not constitute the creation of an attorney/client relationship. Any decision with respect to legal services is important and should not be based solely upon this, or any other, advertisement. Material provided herein is for informational purposes only and is not intended to constitute legal advice. We cannot guarantee that all material on this site will be complete or current, so nothing herein should be relied upon without consulting with an attorney to insure that it is applicable to any particular situation. FREE BACKGROUND INFORMATION AVAILABLE UPON REQUEST.